Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease
Repurposing of the anthelminthic drug niclosamide was proposed as an effective treatment for inflammatory airway diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease. Niclosamide may also be effective for the treatment of viral respiratory infections, such as SARS-CoV-...
Main Authors: | Jiraporn Ousingsawat, Raquel Centeio, Inês Cabrita, Khaoula Talbi, Oliver Zimmer, Moritz Graf, Achim Göpferich, Rainer Schreiber, Karl Kunzelmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/3/1085 |
Similar Items
-
Pharmacological Inhibition and Activation of the Ca<sup>2+</sup> Activated Cl<sup>−</sup> Channel TMEM16A
by: Raquel Centeio, et al.
Published: (2020-04-01) -
TMEM16A/F support exocytosis but do not inhibit Notch-mediated goblet cell metaplasia of BCi-NS1.1 human airway epithelium
by: Raquel Centeio, et al.
Published: (2023-05-01) -
Mucus Release and Airway Constriction by TMEM16A May Worsen Pathology in Inflammatory Lung Disease
by: Raquel Centeio, et al.
Published: (2021-07-01) -
CLCA1 Regulates Airway Mucus Production and Ion Secretion Through TMEM16A
by: Raquel Centeio, et al.
Published: (2021-05-01) -
Calmodulin-Dependent Regulation of Overexpressed but Not Endogenous TMEM16A Expressed in Airway Epithelial Cells
by: Khaoula Talbi, et al.
Published: (2021-09-01)